Insider Transactions Reported by 21 Insiders of DiaMedica Therapeutics Inc.

Symbol
DMAC on Nasdaq
Location
Minneapolis, MN

Insiders trading volume in the past year

DiaMedica Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Jan Stahlberg 10%+ Owner $75,679,855 +$18,989,576 +33% 17 Nov 2025
Thomas von Koch 10%+ Owner $29,342,519 +$9,999,997 +52% 23 Jul 2025
Richard Jacinto II 10%+ Owner $17,355,880 +$1,400,000 +8.8% 23 Jul 2025
Randall Michael Giuffre Director $3,727,417 02 Jan 2026
David J. Wambeke Chief Business Officer $3,420,969 01 Jun 2025
Richard D. Pilnik Director $1,440,505 07 Apr 2025
Parsons James T. Director $824,730 02 Jan 2026
Dietrich John Pauls President & CEO, Director $445,155 01 Jun 2025
Charles Pauling Semba Director $403,848 02 Jan 2026
Scott Kellen CFO & Secretary $209,562 01 Jun 2025
Amy L. Burroughs Director $205,206 03 Jan 2023
Richard Kuntz Director $129,332 01 Jun 2025
Harry W. Alcorn Jr. SVP, Clinical Operations $123,147 15 Sep 2021
Dominic R. Cundari Chief Commercial Officer $7,840 01 Jun 2024
Daniel J. O'Connor Director $0 20 Feb 2025
Tanya Lewis Director $0 01 Jun 2025
Julie Krop Chief Marketing Officer 11 Aug 2025
Sydney A. Gilman VP, Regulatory Affairs 28 Jul 2021
Kirsten L. Gruis Chief Medical Officer 01 Jun 2023
Julie VanOrsdel Daves SVP Clinical Development Oper. 01 Jun 2023
Masuoka K. Lorianne Chief Medical Officer 22 Jan 2024

Recent Insider Transactions by Companies or Individuals for DiaMedica Therapeutics Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Parsons James T. DMAC Common Stock Award 11.5% 10,095 97,949 02 Jan 2026 Direct
Randall Michael Giuffre DMAC Common Stock Award 1.57% 6,175 398,587 02 Jan 2026 Direct
Charles Pauling Semba DMAC Common Stock Award 7.52% 3,355 47,963 02 Jan 2026 Direct
Jan Stahlberg DMAC Common Shares Purchase 0.84% $626,817 $8.57 73,099 8,825,742 25 Nov 2025 See Footnote
Jan Stahlberg DMAC Common Shares Purchase 0.46% $317,721 $7.89 40,253 8,752,643 24 Nov 2025 See Footnote
Jan Stahlberg DMAC Common Shares Purchase 2.46% $1,547,574 $7.41 208,872 8,712,390 21 Nov 2025 See Footnote
Parsons James T. DMAC Common Stock Options Exercise 15.8% 12,000 87,854 21 Nov 2025 Direct
Parsons James T. DMAC Stock Option (right to buy) Options Exercise -100% -12,000 0 21 Nov 2025 Direct
Jan Stahlberg DMAC Common Shares Purchase 1.53% $951,213 $7.41 128,426 8,503,518 20 Nov 2025 See Footnote
Jan Stahlberg DMAC Common Shares Purchase 2.95% $1,732,361 $7.21 240,352 8,375,092 19 Nov 2025 See Footnote
Jan Stahlberg DMAC Common Shares Purchase 2.3% $1,234,618 $6.75 182,882 8,134,740 18 Nov 2025 See Footnote
Jan Stahlberg DMAC Common Shares Purchase 2.41% $1,221,165 $6.52 187,393 7,951,858 17 Nov 2025 See Footnote
Jan Stahlberg DMAC Common Shares Purchase 0.66% $304,632 $6.00 50,772 7,764,465 27 Aug 2025 See Footnote
Jan Stahlberg DMAC Common Shares Purchase 0.78% $357,888 $6.00 59,648 7,713,693 26 Aug 2025 See Footnote
Jan Stahlberg DMAC Common Shares Purchase 4.62% $2,029,252 $6.00 338,265 7,654,045 25 Aug 2025 See Footnote
Jan Stahlberg DMAC Common Shares Purchase 0.82% $356,576 $5.96 59,788 7,315,780 22 Aug 2025 See Footnote
Jan Stahlberg DMAC Common Shares Purchase 0.67% $287,028 $5.96 48,172 7,255,992 21 Aug 2025 See Footnote
Jan Stahlberg DMAC Common Shares Purchase 1% $416,495 $5.86 71,107 7,207,820 20 Aug 2025 See Footnote
Jan Stahlberg DMAC Common Shares Purchase 0.12% $49,398 $6.00 8,233 7,136,713 15 Aug 2025 See Footnote
Jan Stahlberg DMAC Common Shares Purchase 1% $421,921 $5.99 70,414 7,128,480 14 Aug 2025 See Footnote
Jan Stahlberg DMAC Common Shares Purchase 4.34% $1,734,918 $5.91 293,601 7,058,066 13 Aug 2025 See Footnote
Julie Krop DMAC Stock Option (right to buy) Award 450,000 450,000 11 Aug 2025 Direct
Jan Stahlberg DMAC Common Shares Purchase 29.6% $5,400,000 $3.50 1,542,857 6,764,465 23 Jul 2025 See Footnote 1
Thomas von Koch DMAC Common Shares Purchase 51.7% $9,999,997 $3.50 2,857,142 8,383,577 23 Jul 2025 See Footnote 1
Richard Jacinto II DMAC Voting Common Shares, no par value per share Purchase 8.77% $1,400,000 $3.50 400,000 4,958,823 23 Jul 2025 By Roth IRA
David J. Wambeke DMAC Stock Option (right to buy) Award 250,000 250,000 01 Jun 2025 Direct
Charles Pauling Semba DMAC Stock Option (right to buy) Award 32,162 32,162 01 Jun 2025 Direct
Dietrich John Pauls DMAC Stock Option (right to buy) Award 600,000 600,000 01 Jun 2025 Direct
Parsons James T. DMAC Stock Option (right to buy) Award 40,739 40,739 01 Jun 2025 Direct
Tanya Lewis DMAC Stock Option (right to buy) Award 32,162 32,162 01 Jun 2025 Direct
Richard Kuntz DMAC Stock Option (right to buy) Award 32,162 32,162 01 Jun 2025 Direct
Scott Kellen DMAC Stock Option (right to buy) Award 225,000 225,000 01 Jun 2025 Direct
Randall Michael Giuffre DMAC Stock Option (right to buy) Award 32,162 32,162 01 Jun 2025 Direct
Richard D. Pilnik DMAC Voting Common Shares, no par value per share Options Exercise 8.3% 24,000 312,995 07 Apr 2025 Direct
Richard D. Pilnik DMAC Stock Option (right to buy) Options Exercise -100% -24,000 0 07 Apr 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.